Omega Therapeutics Inc (OMGA)
2.08
-0.16
(-7.14%)
USD |
NASDAQ |
Jun 28, 16:00
2.01
-0.07
(-3.37%)
After-Hours: 20:00
Omega Therapeutics Cash from Investing (Quarterly): 4.465M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.465M |
| December 31, 2023 | 2.14M |
| September 30, 2023 | -0.724M |
| June 30, 2023 | 24.05M |
| March 31, 2023 | 22.05M |
| December 31, 2022 | 17.65M |
| September 30, 2022 | 10.59M |
| June 30, 2022 | 11.27M |
| March 31, 2022 | -57.57M |
| Date | Value |
|---|---|
| December 31, 2021 | -39.13M |
| September 30, 2021 | -0.353M |
| June 30, 2021 | -0.866M |
| March 31, 2021 | -0.048M |
| December 31, 2020 | -0.523M |
| September 30, 2020 | -1.046M |
| June 30, 2020 | -0.171M |
| March 31, 2020 | -0.068M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-57.57M
Minimum
Mar 2022
24.05M
Maximum
Jun 2023
-0.4875M
Average
-0.068M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Altimmune Inc | -39.52M |
| Macrogenics Inc | 24.79M |
| Viking Therapeutics Inc | -459.79M |
| vTv Therapeutics Inc | -- |
| Rhythm Pharmaceuticals Inc | 30.05M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.80M |
| Cash from Financing (Quarterly) | -1.07M |
| Free Cash Flow | -78.61M |
| Free Cash Flow Per Share (Quarterly) | -0.2238 |
| Free Cash Flow to Equity (Quarterly) | -11.35M |
| Free Cash Flow Yield | -68.55% |